Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice

Free Radical Biology and Medicine

Volumn 87, Issue , 2015, Pages 58-68

  Song, Guohua ^a   Zong, Chuanlong ^a   Zhang, Zhaoqiang ^a   Yu, Yang ^a   Yao, Shutong ^a   Jiao, Peng ^a   Tian, Hua ^a   Zhai, Lei ^a   Zhao, Hui ^a   Tian, Shuyan ^a   Zhang, Xiangjian ^b   Wu, Yun ^a   Sun, Xuejun ^c   Qin, Shucun ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b Hebei Collaborative Innovation Center for Cardio cerebrovascular Disease   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endoplasmic reticulum stress; Free radicals; Hydrogen; Macrophage apoptosis; NF E2 related factor 2; Plaque stability

Indexed keywords

4 PHENYLBUTYRIC ACID; ACETYLCYSTEINE; CASPASE 3; COLLAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; AORTA ATHEROSCLEROSIS; APOPTOSIS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; FOAM CELL; HUMAN; HYDROGENATION; IN VITRO STUDY; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; HUMANS; HYDROGEN; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PLAQUE, ATHEROSCLEROTIC; REACTIVE OXYGEN SPECIES; RECEPTORS, LDL; RECEPTORS, OXIDIZED LDL; SIMVASTATIN;

EID: 84939454161     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.018     Document Type: Article

References (38)

1. J.C. Grivel, O. Ivanova, N. Pinegina, P.S. Blank, A. Shpektor, L.B. Margolis, and E. Vasilieva Activation of T lymphocytes in atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 31 2011 2929 2937
2. E. Falk Pathogenesis of atherosclerosis J. Am. Coll. Cardiol. 47 2006 C7-12
3. J. Cai, T.S. Hatsukami, M.S. Ferguson, W.S. Kerwin, T. Saam, B. Chu, N. Takaya, N.L. Polissar, and C. Yuan In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology Circulation 112 2005 3437 3444
4. W. Palinski, and C. Napoli Unraveling pleiotropic effects of statins on plaque rupture Arterioscler. Thromb. Vasc. Biol. 22 2002 1745 1750
5. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
6. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler. Thromb. Vasc. Biol. 25 2005 2255 2264
7. B. Halvorsen, K. Otterdal, T.B. Dahl, M. Skjelland, L. Gullestad, E. Oie, and P. Aukrust Atherosclerotic plaque stability - what determines the fate of a plaque? Prog. Cardiovasc. Dis. 51 2008 183 194
8. I. Ohsawa, M. Ishikawa, K. Takahashi, M. Watanabe, K. Nishimaki, K. Yamagata, K. Katsura, Y. Katayama, S. Asoh, and S. Ohta Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals Nat. Med. 13 2007 688 694
9. H. Amitani, A. Asakawa, K. Cheng, M. Amitani, K. Kaimoto, M. Nakano, M. Ushikai, Y. Li, M. Tsai, J.B. Li, M. Terashi, H. Chaolu, R. Kamimura, and A. Inui Hydrogen improves glycemic control in type 1 diabetic animal model by promoting glucose uptake into skeletal muscle PLoS One 8 2013 e53913
10. S. Kajiyama, G. Hasegawa, M. Asano, H. Hosoda, M. Fukui, N. Nakamura, J. Kitawaki, S. Imai, K. Nakano, M. Ohta, T. Adachi, H. Obayashi, and T. Yoshikawa Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance Nutr. Res. 28 2008 137 143
11. B. Gharib, S. Hanna, O.M. Abdallahi, H. Lepidi, B. Gardette, and M. De Reggi Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation C. R. Acad. Sci. III 324 2001 719 724
12. H. Sun, L. Chen, W. Zhou, L. Hu, L. Li, Q. Tu, Y. Chang, Q. Liu, X. Sun, M. Wu, and H. Wang The protective role of hydrogen-rich saline in experimental liver injury in mice J. Hepatol. 54 2011 471 480
13. C. Zong, G. Song, S. Yao, L. Li, Y. Yu, L. Feng, S. Guo, T. Luo, and S. Qin Administration of hydrogen-saturated saline decreases plasma low-density lipoprotein cholesterol levels and improves high-density lipoprotein function in high-fat diet-fed hamsters Metabolism 61 2012 794 800
14. G. Song, M. Li, H. Sang, L. Zhang, X. Li, S. Yao, Y. Yu, C. Zong, Y. Xue, and S. Qin Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome J. Lipid Res. 54 2013 1884 1893
15. G. Song, H. Tian, S. Qin, X. Sun, S. Yao, C. Zong, Y. Luo, J. Liu, Y. Yu, H. Sang, and X. Wang Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice Atherosclerosis 221 2012 55 65
16. I. Ohsawa, K. Nishimaki, K. Yamagata, M. Ishikawa, and S. Ohta Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice Biochem. Biophys. Res. Commun. 377 2008 1195 1198
17. J. Cai, Z. Kang, K. Liu, W. Liu, R. Li, J.H. Zhang, X. Luo, and X. Sun Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model Brain Res. 1256 2009 129 137
18. W. Ni, K. Egashira, S. Kitamoto, C. Kataoka, M. Koyanagi, S. Inoue, K. Imaizumi, C. Akiyama, K.I. Nishida, and A. Takeshita New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice Circulation 103 2001 2096 2101
19. A. Boullier, Y. Li, O. Quehenberger, W. Palinski, I. Tabas, J.L. Witztum, and Y.I. Miller Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages Arterioscler. Thromb. Vasc. Biol. 26 2006 1169 1176
20. M. Ayaori, S. Sawada, A. Yonemura, N. Iwamoto, M. Ogura, N. Tanaka, K. Nakaya, M. Kusuhara, H. Nakamura, and F. Ohsuzu Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages Arterioscler. Thromb. Vasc. Biol. 26 2006 163 168
21. L. Iuliano, A.R. Colavita, C. Camastra, V. Bello, C. Quintarelli, M. Alessandroni, F. Piovella, and F. Violi Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole Br. J. Pharmacol. 119 1996 1438 1446
22. C.A. Schuyler, N.N. Ta, Y. Li, M.F. Lopes-Virella, and Y. Huang Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice J. Endocrinol. 210 2011 37 46
23. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
24. B. Dietel, I. Cicha, C.J. Voskens, E. Verhoeven, S. Achenbach, and C.D. Garlichs Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells Atherosclerosis 230 2013 92 99
25. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat. Rev. Immunol. 10 2010 36 46
26. H. Tsukano, T. Gotoh, M. Endo, K. Miyata, H. Tazume, T. Kadomatsu, M. Yano, T. Iwawaki, K. Kohno, K. Araki, H. Mizuta, and Y. Oike The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 30 2010 1925 1932
27. J.J. Li, X. Meng, H.P. Si, C. Zhang, H.X. Lv, Y.X. Zhao, J.M. Yang, M. Dong, K. Zhang, S.X. Liu, X.Q. Zhao, F. Gao, X.L. Liu, T.X. Cui, and Y. Zhang Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis Arterioscler. Thromb. Vasc. Biol. 32 2012 1158 1166
28. N.R. Madamanchi, A. Vendrov, and M.S. Runge Oxidative stress and vascular disease Arterioscler. Thromb. Vasc. Biol. 25 2005 29 38
29. F. Tian, S. Grimaldo, M. Fujita, J. Cutts, N.L. Vujanovic, and L.Y. Li The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation J. Immunol. 179 2007 3742 3751
30. D.Q. Tran TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells J. Mol. Cell. Biol. 4 2012 29 37
31. S. Yao, C. Zong, Y. Zhang, H. Sang, M. Yang, P. Jiao, Y. Fang, N. Yang, G. Song, and S. Qin Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression J. Atheroscler. Thromb. 20 2013 94 107
32. C.M. Scull, and I. Tabas Mechanisms of ER stress-induced apoptosis in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 31 2011 2792 2797
33. E. Thorp, G. Li, T.A. Seimon, G. Kuriakose, D. Ron, and I. Tabas Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP Cell Metab. 9 2009 474 481
34. I. Tabas Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress Antioxid. Redox Signaling 11 2009 2333 2339
35. T. Seimon, and I. Tabas Mechanisms and consequences of macrophage apoptosis in atherosclerosis J. Lipid Res. 50 Suppl 2009 S382 S387
36. S. Makabe, Y. Takahashi, H. Watanabe, M. Murakami, T. Ohba, and H. Ito Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway Atherosclerosis 213 2010 377 384
37. D. Chartoumpekis, P.G. Ziros, A. Psyrogiannis, V. Kyriazopoulou, A.G. Papavassiliou, and I.G. Habeos Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway Biochem. Biophys. Res. Commun. 396 2010 463 466
38. S.B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, and J.A. Diehl Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209